Why the study?
Does fludrocortisone improve cardiac function in a patient with takotsubo cardiomyopathy secondary to adrenal insufficiency?
Population
A middle-aged woman with refractory hypotension, hypoglycemia, and takotsubo cardiomyopathy
Design
Case report
Key result
Fludrocortisone improved left ventricular ejection fraction from 30-35% to 45-50% in a middle-aged woman with secondary adrenal insufficiency and takotsubo cardiomyopathy.
Authors
Loading...
May warrant fludrocortisone in adrenal insufficiency-related takotsubo; hypothesis-generating pending prospective validation.
Case Report (n=1)
No
Does fludrocortisone improve cardiac function in a patient with takotsubo cardiomyopathy secondary to adrenal insufficiency?
Effect estimate: LVEF improved from 30-35% to 45-50%
Absolute Event Rate: 45% vs 30%
Secondary adrenal insufficiency is a rare cause of takotsubo cardiomyopathy that can be effectively managed with fludrocortisone to improve cardiac function and hemodynamic stability.
Khalid et al. (2026) conducted a case report in Middle-aged woman (44 years) with secondary adrenal insufficiency and takotsubo cardiomyopathy due to chronic topical steroid use (n=1). Fludrocortisone was evaluated on Improvement in left ventricular ejection fraction (LVEF) (LVEF improved from 30-35% to 45-50%). Fludrocortisone improved left ventricular ejection fraction from 30-35% to 45-50% in a middle-aged woman with secondary adrenal insufficiency and takotsubo cardiomyopathy.